Prediction of High Ovarian Response After Assisted Reproductive Techniques

Key facts

Sponsor

Instituto de Investigacion Sanitaria La Fe

Principal Investigator

Vicente Montañana-Ramirez, MD, PhD

Instituto de Investigaciones Sanitarias La Fe

Enrollment

300 target

Eligibility

18-39 years · FEMALE

Timeline

2013 – 2015

Study locations (1)

• La Fe University Hospital, Valencia, Valencia, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07043322
  Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
  Tanta University

See all trials for Ovarian hyperstimulation syndrome →